A carregar...
Experience with sorafenib in the treatment of advanced renal cell carcinoma
The molecular-targeted agent sorafenib is the first anticancer agent able to slow the progression of advanced/metastatic renal cell carcinoma, a tumor that was formerly refractory to conventional therapy. Experience from everyday clinical practice and investigations exploring the suitability of this...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3491759/ https://ncbi.nlm.nih.gov/pubmed/23205057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287212457216 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|